The global thyroid ablation devices market is anticipated to grow at a considerable CAGR of 9.8% during the forecast period (2023-2030). The increasing prevalence of thyroid nodules owing to changing lifestyles, increased adoption of an unhealthy diet, and lowiodine intake has created its treatment demand. Thyroid ablation devices are mostly used and effective for the treatment of thyroid nodules. Thyroid ablation procedures are efficient since it is less invasive, and consequently has a potential of fewer complications also helps in continuing more of the thyroid and help patients maintain normal thyroid function.
Browse the full report description of “Thyroid Ablation Devices Market Size, Share & Trends Analysis Report by Type (Radiofrequency Ablation, Microwave Ablation, and Others), by Product (Thermal-based Devices and Non-thermal-based Devices), By Application, (Thyroid Cancer and Thyroid Nodules), by End-use (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/thyroid-ablation-devices-market
According to the NIH, the incidences of thyroid nodules has been rising in the Saudi population, with women more likely to develop thyroid cancer than men. Besides, thyroid cancer is the second most common malignancy among Saudi women. Similarly, in the Gulf countries, thyroid cancer is the fifth most common cancer among women, and the rates of thyroid malignancies are significantly higher in women from these countries than in those from the US. Therefore, it is crucial to differentiate between benign and malignant thyroid nodules in this population. Furthermore, the rising number of approvals from country’s authorizations boosted the demand for thyroid ablation devices for the treatment of thyroid nodules. For instance, in July 2023, Baird Medical Investment Holdings Ltd, a microwave ablation medical device developer and provider in China, received approval from China's National Medical Products Administration for its Class III registered microwave ablation disposable needle for the treatment of benign thyroid nodules. Furthermore, a recently approved technique for radio-frequency ablation treats or prevents problems caused by thyroid nodules, providing an alternative to surgical removal of the gland. In August 2020, Stanford Health Care introduced new, less invasive treatment for benign thyroid nodules. Such developments are making significant contribution to the market growth.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Type
o By Product
o By Application
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
Competitive Landscape-including Boston Scientific Corp., Integra LifeSciences Corp., Johnson & Johnson Services, Inc., Medtronic Plc, and others.
Key questions addressed by the report
Global Thyroid Ablation Devices Market Report Segment
By Type
By Product
By Application
By End-User
Global Thyroid Ablation Devices Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/thyroid-ablation-devices-market